Branded generics market
Branded generics market Projected to generate significant sales for the market players over the forecast period
Branded generics market estimated to be valued US$ 224 billion in 2017 and poised to grow at CAGR 7.7 %. The market for branded generics projected to reach US$ 350 Billion by 2023
An outline on branded generics market
The report provides in-depth information about the market size, regional market share, current and future market strategies and goals. The report also covers restraints, unmet needs, and trends that are currently affecting the market. And lastly, the report tracks recent innovations, key developments and startup’s details that are actively working in the market.
Branded generics market report includes new product introductions, recent drug patent expiration data, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed branded generics market to better equip clients with possible investment opportunities across the emerging markets (Regional Investment Hot-Spots) and market unmet needs (Product/Disease Opportunities). Key stakeholders of the branded generics market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of branded generics.
Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-4H8Z4LpNMLEuOnnx
The branded generics market is divided into following categories-
1. Diseases Indication
• Cardiovascular Diseases
• Diabetes
• Cancer
• Neurological Disorders
• Gastrointestinal Diseases
• Dermatology Diseases
• Others
2. Route of Administration
• Oral
• Parenteral
• Topical
• Others
3. End-users
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-c654SbFYO64MsOhu
And lastly, on the basis of geographical regions, the branded generic market is divided into- North America, Europe, Asia-Pacific, the Middle East and Africa and Latin America. The Asia-Pacific market is expected to lead the global branded generics market in terms of revenue owing to higher out-of-pocket healthcare expenditure and lack of universal health coverage. Moreover, countries like India, China, and ASEAN countries presented are showing better market opportunities for the existing and new players in the market. Regions such as Asia Latin America and Eastern Europe projected to grow at significant CAGR.
Some of the key players in the global branded generics market include Abbott Laboratories (U.S.), Apotex Inc. (Canada), AstraZeneca (U.K), Reddy’s Laboratories Ltd. (India), GlaxoSmithKline plc (U.K), Mylan N.V. (U.S.), Pfizer Inc. (U.S), Novartis AG (Switzerland), Sanofi (France), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd (Israel), Valeant Pharmaceuticals International, Inc. (Canada) are to name few. Market players are focusing on mergers and acquisitions, collaborations, partnerships, strategic alliances, and product diversification to increase the geographic presence in global branded generics market. Moreover, players are entering into a distribution agreement with local pharmaceutical companies to overcome the market access barrier in developing regions. The branded generics market estimated to be valued US$ 224 billion in 2017 and poised to grow at CAGR 7.7 %. The market for branded generics projected to reach US$ 350 Billion by 2023.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-14mlyhjMGhVjZqa3
The market for branded generics expected to register around double-digit growth rate in emerging economies owing to the widespread prevalence of lifestyle and chronic diseases like diabetes and cardiovascular diseases. The growing lifestyle changes along with rising disposable income in middle classes are factors expected to prompt the market growth in near future. Developed pharmaceutical markets like North America, Europe, and Japan has been witnessing relatively slower market growth in comparing with developing markets owing to fewer new product approvals from the regulatory bodies and bleak late-stage pipeline. This has been led to the change in focus by several multinational pharmaceutical giants from matured markets to developing markets to tap ever-growing market opportunities in these regions. Moreover, increasing product patent expirations expected to boost the branded generics revenue growth in developing and mature markets across the globe.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com